Financial Result
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sattva Sukun Lifecare (formerly Mayukh Dealtrade) reported strong revenue growth with standalone H1 FY26 net sales rising to Rs. 317.53 lakhs (vs Rs. 225.60 lakhs in H1 FY25, up ~41%) and standalone H1 PAT growing to Rs. 125.53 lakhs (vs Rs. 95.57 lakhs, up ~31%). Consolidated H1 FY26 net sales surged to Rs. 1,805.88 lakhs and consolidated PAT to Rs. 131.55 lakhs, driven by newly consolidated subsidiaries. The company completed a Rights Issue of Rs. 19.16 crores during the quarter, allotting 19.16 crore equity shares of Re. 1 each. No deviation in use of rights issue proceeds was reported and there are no loan defaults. However, operating cash flow was deeply negative at Rs. -229.35 lakhs (standalone) and Rs. -1,317.79 lakhs (consolidated), with profits not converting to cash due to working capital expansion.
Top-line and profit growth are strong on the surface, but the sharp divergence between reported profits and negative operating cash flows is a red flag for shareholders, suggesting working capital is consuming cash. Equity dilution from the bonus issue and large rights issue has compressed EPS significantly, though the fund raise supports the company's expansion plans.